Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Aronson

Showing results (411-420 of 522) with videos related to

Pageof 53
Sort By:
Cancer Medicine|March 8, 2024
Do Hispanic Puerto Rican men have worse outcomes after radical prostatectomy? Results from SEARCHLourdes Guerrios-Rivera, Jessica L Janes, Amanda M De Hoedt, et al.
Molecular Therapy. Methods & Clinical Development|July 9, 2020
A Quantitative <i>In Vitro</i> Potency Assay for Adeno-Associated Virus Vectors Encoding for the <i>UGT1A1</i> TransgeneSem J Aronson, Robert S Bakker, Sascha Moenis, et al.
The Journal of Urology|September 4, 2019
Racial Discrepancies in Overall Survival among Men Treated with <sup>223</sup>RadiumHanson Zhao, Lauren E Howard, Amanda De Hoedt, et al.
Cancer|June 30, 2017
Validation of the 2015 prostate cancer grade groups for predicting long-term oncologic outcomes in a shared equal-access health systemAriel A Schulman, Lauren E Howard, Kae Jack Tay, et al.
Bioinformatics (Oxford, England)|September 2, 2022
I2b2-etl: Python application for importing electronic health data into the informatics for integrating biology and the bedside platformKavishwar B Wagholikar, Layne Ainsworth, David Zelle, et al.
Cancer|December 11, 2014
Is clinical stage T2c prostate cancer an intermediate- or high-risk disease?Zachary Klaassen, Abhay A Singh, Lauren E Howard, et al.
The Journal of Urology|June 16, 2009
Body mass index and prostate specific antigen as predictors of adverse pathology and biochemical recurrence after prostatectomyLionel L Bañez, Leon Sun, Bruce J Trock, et al.
Molecular Therapy. Methods & Clinical Development|January 29, 2021
Efficacy of AAV8-h<i>UGT1A1</i> with Rapamycin in neonatal, suckling, and juvenile rats to model treatment in pediatric CNs patientsXiaoxia Shi, Sem J Aronson, Lysbeth Ten Bloemendaal, et al.
Cancer|August 11, 2006
Clinical and pathologic outcome after radical prostatectomy for prostate cancer patients with a preoperative Gleason sum of 8 to 10Patrick J Bastian, Mark L Gonzalgo, William J Aronson, et al.
The Prostate|December 14, 2021
Prostate weight and prostate cancer outcomes after radical prostatectomy: Results from the SEARCH cohort studySean Kennedy Barlow, Taofik Oyekunle, Jessica L Janes, et al.
Pageof 53

Showing results (411-420 of 522) with videos related to

Sort By:
Pageof 53
Cancer Medicine|March 8, 2024
Do Hispanic Puerto Rican men have worse outcomes after radical prostatectomy? Results from SEARCHLourdes Guerrios-Rivera, Jessica L Janes, Amanda M De Hoedt, et al.
Molecular Therapy. Methods & Clinical Development|July 9, 2020
A Quantitative <i>In Vitro</i> Potency Assay for Adeno-Associated Virus Vectors Encoding for the <i>UGT1A1</i> TransgeneSem J Aronson, Robert S Bakker, Sascha Moenis, et al.
The Journal of Urology|September 4, 2019
Racial Discrepancies in Overall Survival among Men Treated with <sup>223</sup>RadiumHanson Zhao, Lauren E Howard, Amanda De Hoedt, et al.
Cancer|June 30, 2017
Validation of the 2015 prostate cancer grade groups for predicting long-term oncologic outcomes in a shared equal-access health systemAriel A Schulman, Lauren E Howard, Kae Jack Tay, et al.
Bioinformatics (Oxford, England)|September 2, 2022
I2b2-etl: Python application for importing electronic health data into the informatics for integrating biology and the bedside platformKavishwar B Wagholikar, Layne Ainsworth, David Zelle, et al.
Cancer|December 11, 2014
Is clinical stage T2c prostate cancer an intermediate- or high-risk disease?Zachary Klaassen, Abhay A Singh, Lauren E Howard, et al.
The Journal of Urology|June 16, 2009
Body mass index and prostate specific antigen as predictors of adverse pathology and biochemical recurrence after prostatectomyLionel L Bañez, Leon Sun, Bruce J Trock, et al.
Molecular Therapy. Methods & Clinical Development|January 29, 2021
Efficacy of AAV8-h<i>UGT1A1</i> with Rapamycin in neonatal, suckling, and juvenile rats to model treatment in pediatric CNs patientsXiaoxia Shi, Sem J Aronson, Lysbeth Ten Bloemendaal, et al.
Cancer|August 11, 2006
Clinical and pathologic outcome after radical prostatectomy for prostate cancer patients with a preoperative Gleason sum of 8 to 10Patrick J Bastian, Mark L Gonzalgo, William J Aronson, et al.
The Prostate|December 14, 2021
Prostate weight and prostate cancer outcomes after radical prostatectomy: Results from the SEARCH cohort studySean Kennedy Barlow, Taofik Oyekunle, Jessica L Janes, et al.
Pageof 53